You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Profile for Argentina Patent: 126033


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 126033

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,517,951 Apr 23, 2033 Otsuka ABILIFY ASIMTUFII aripiprazole
11,097,007 Apr 23, 2033 Otsuka ABILIFY ASIMTUFII aripiprazole
11,638,757 Apr 23, 2033 Otsuka ABILIFY ASIMTUFII aripiprazole
12,016,927 Apr 23, 2033 Otsuka ABILIFY ASIMTUFII aripiprazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR126033: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the Scope of Patent AR126033?

Patent AR126033 pertains to a pharmaceutical invention granted in Argentina, with its primary focus on a specific drug formulation or process. The detailed scope encompasses the inventive features that distinguish it from prior art, primarily targeting a novel remedy, formulation, or manufacturing process.

The patent's scope can be summarized as covering:

  • A specific chemical compound or composition
  • A novel formulation including the compound
  • A unique synthesis or manufacturing process
  • Use claims directed toward a particular medical indication

The precise scope depends on the claims, which are structured to protect the inventive concept within the limits of patentability.

What Do the Claims Cover?

The claims in AR126033 can be divided into independent and dependent claims.

Independent Claims

Typically, independent claims define the core invention. In patent AR126033, they likely specify:

  • A composition comprising a specific active pharmaceutical ingredient (API) in a defined concentration
  • A method of preparing the pharmaceutical composition with particular steps
  • A use of the composition for treating a specific medical condition

Dependent Claims

Dependent claims narrow the scope, adding specifics like:

  • Specific excipients or stabilizers
  • Dosage forms such as tablets, injections, or topical formulations
  • Conditions of use, including administration routes or dosage schedules

Sample Claim Structure (Hypothetical):

  • Claim 1 (independent): A pharmaceutical composition comprising compound X and excipient Y for use in treating condition Z.
  • Claim 2: The composition according to claim 1, wherein the compound X is present at a concentration of X mg.
  • Claim 3: A process for preparing the composition of claim 1, comprising steps A, B, and C.

Since the exact claim language and boundaries are essential for understanding scope, the analysis assumes typical formulations aligned with Argentine patent law.

Patent Landscape for Argentine Pharmaceutical Patents

National Patent System Overview

Argentina's patent system is governed by the Patent Law No. 24,481, aligned with the TRIPS Agreement. Patents generally grant for 20 years from the filing date, providing territorial protection only within Argentina.

Patent Filings and Trends

  • The number of pharmaceutical patent applications in Argentina has increased over the last decade, driven by local R&D and international patent filings.
  • Patent applications often focus on formulations, manufacturing processes, and new uses of known compounds.
  • Major patent filers include multinational pharma firms, local biotech companies, and universities.

Key Players and Patent Families

Most pharmaceutical patents in Argentina are part of larger international patent families, with filings in major jurisdictions such as the US, Europe, and Argentina.

  • Leading applicants often file in Argentina to secure market exclusivity or strategic positioning.
  • Patent family AR126033 appears to be part of a broader patent portfolio for a specific compound or formulation.

Patent Status and Legal Environment

  • Argentina maintains a patent approval process that includes substantive examination, with some applications facing delays.
  • Patent enforcement is subject to local courts; infringement can be challenged on grounds of invalidity or non-compliance.

Similar Patents and Overlapping Rights

  • A significant landscape of patents exists for the same or similar compounds and formulations.
  • Freedom-to-operate (FTO) analyses are necessary when commercializing drugs related to patent AR126033, especially considering potential overlapping patents.

Patent Term and Maintenance

  • Patents are granted for 20 years from filing, subject to renewal fees.
  • Inactive or abandoned patents are common; renewal status should be verified periodically.

Critical Considerations for Patent Strategy

  • Patent scope must be sufficiently broad to prevent design-arounds but specific enough to withstand validity challenges.
  • Complementary patents, including secondary formulations or methods, extend market protection.
  • Patent expiration timelines influence lifecycle management and commercialization plans.

Summary of Key Data

Aspect Details
Filing date Likely within the last 20 years (exact date not provided)
Patent term 20 years from filing (subject to maintenance)
Patent status Assumed granted; status should be verified via official registry
Claim type Composition, process, and use claims
Main applicants Multinational or local entities (unspecified)
Overlap with other patents Overlapping patents exist for similar compounds/formulations

Key Takeaways

  • Patent AR126033's scope covers specific pharmaceutical compositions, processes, or uses associated with the inventive claim language.
  • Its claims likely include broad formulation and method protections, with narrower dependent claims covering specifics.
  • The patent landscape in Argentina shows increasing filings in the pharmaceutical sector, with strategic importance for local commercialization.
  • Accurate FTO analysis must consider overlapping patents, patent expiry, and enforceability within Argentina.
  • Monitoring maintenance status and reviewing licensing opportunities is crucial for effective lifecycle management.

FAQs

1. What is the typical scope of patents in Argentina for pharmaceuticals?
Patents cover active ingredients, formulations, manufacturing processes, and specific therapeutic uses, often with broad claims tailored to the invention.

2. How do Argentine patent claims impact clinical or commercial applications?
Claims define the protected scope; infringing activities risk legal action if they fall within the claims' boundaries.

3. Are there specific challenges with patent enforcement in Argentina?
Yes. Enforcement can be complex, experience with patent litigation varies, and legal challenges to validity are common.

4. How does patent renewal work in Argentina?
Patents require annual renewal fees, with lapses leading to loss of protection unless rectified early.

5. How does patent landscape analysis inform R&D investments in Argentina?
Understanding overlapping rights, expiry dates, and patent granularity helps assess freedom-to-operate and potential licensing or infringement risks.


References

[1] Argentine Patent Law No. 24,481 (1996).
[2] World Intellectual Property Organization. (2023). Patent statistics for Argentina.
[3] Instituto Nacional de Propiedad Industrial (INPI). Patent database and application status.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.